Table 2.
Initial diagnostics
| fMSC-treated cats |
Placebo cats |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 1 | 2 | 3 | 4 | |
| Histopathology | Mod | NA | NA | NA | NA | NA | NA | NA | Mod | Mod | NA |
| Albumin* | 2.9 | 3.5 | 3.7 | 3.2 | 2.9 | 3.5 | 3.0 | 3.4 | 4.6 | 3.3 | 3.8 |
| Cobalamin † | 166 | 425 | >1000 | >1000 | >1000 | 151 | <150 | >1000 | 890 | 997 | >1000 |
| Folate | 22.3 | 37.8 | 30.4 | 58.2 | 24.2 | 15.9 | 23.4 | 16.1 | 25 | 14.3 | 11.7 |
| fPLI ‡ | 0.6 | 1.0 | 3.0 | 1.8 | 4.0 | 2.4 | 9.2 | 1.6 | 2.4 | 5.2 | 2.3 |
| fTLI § | 10.7 | 126.1 | 47.5 | 41.6 | 39.6 | 47.8 | 55.0 | 73.0 | 38.9 | 34.0 | 31.5 |
*
3.1–4.4 g/dl
†
290–1400 ng/l
‡
0.1–3.5 µg/l
§
12–82 µg/l
fMSC = feline adipose-derived mesenchymal stem cells; fPLI = feline pancreatic lipase immunoreactivity; fTLI = feline trypsin-like immunoreactivity; Mod = moderate lymphocytic–plasmacytic inflammation; NA = not available